Paper33009382
Targeted scavenging of extracellular ROS relieves suppressive immunogenic cell death.
Deng H and 7 others. Nat Commun, 2020. Cited by 197 papers, by iCite.
Cite this record
ConductScience Library. Targeted scavenging of extracellular ROS relieves suppressive immunogenic cell death. Papers, record 33009382. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33009382
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Extracellular Space | Major topic |
| Free Radical Scavengers | Major topic |
| Immunogenic Cell Death | Major topic |
| Reactive Oxygen Species | Major topic |
| Animals | |
| Cell Line, Tumor | |
| Dendritic Cells | |
| HMGB1 Protein | |
| Mice, Inbred BALB C | |
| Particle Size | |
| Polyethylene Glycols | |
| Tumor Microenvironment |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| ZIA EB000073 | Intramural NIH HHS | United States | ZIAEB000073 | PubMed |
Source NIH RePORTER
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 34210986 | Author Correction: Targeted scavenging of extracellular ROS relieves suppressive immunogenic cell death. | https://conductscience.org/library/papers/34210986 |
Source PubMed
Cited by86
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 197 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42740837 | Research Progress of Multicomponent Co-Loaded Nanomedicine Delivery Systems for Tumor Immunotherapy. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42740837 | PubMed |
| 42576968 | T-cell activity feedback-guided photothermal immunotherapy enabled by immune-responsive redox nanodots. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42576968 | PubMed |
| 42540416 | Hydrogel coatings for titanium implants: From smart stimuli-responsive strategies to multimodal bone regeneration. | Bioact Mater | 2026 | https://conductscience.org/library/papers/42540416 | PubMed |
| 42494420 | Erythrocyte-inspired biomaterials for cancer immunotherapy: Integration within the cancer-immunity cycle. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42494420 | PubMed |
| 42101631 | Redox-modulation of regulated cell death: implications for synergistic anticancer therapies. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/42101631 | PubMed |
| 42001355 | Plant-derived extracellular vesicles as a promising therapeutic and drug delivery strategy for tumor oxidative stress and inflammation. | Discov Nano | 2026 | https://conductscience.org/library/papers/42001355 | PubMed |
| 41914238 | Repurposing Hetrombopag for Multiple Myeloma by Targeting PNPO: A Celastrol-Inspired Approach. | Basic Clin Pharmacol Toxicol | 2026 | https://conductscience.org/library/papers/41914238 | PubMed |
| 41821152 | Engineering MnPt Bimetallic Nanozymes for Cascade Enzymatic Therapy and Enhanced Radio-Immunotherapy. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41821152 | PubMed |
| 41639675 | Cascade catalytic nanozyme platform for combined antibacterial, anti-inflammatory, and pro-healing therapy of infected diabetic wounds. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/41639675 | PubMed |
| 41614403 | Mitochondria in T‑cell tumor immunity and tumor therapies targeting mitochondria (Review). | Oncol Rep | 2026 | https://conductscience.org/library/papers/41614403 | PubMed |
| 41365865 | Inhibiting the formation of neutrophil extracellular traps to prevent the recurrence of post-operative glioblastoma. | Nat Commun | 2025 | https://conductscience.org/library/papers/41365865 | PubMed |
| 41363830 | Emerging Advances in Nanomedicine for Targeted Cancer Photoimmunotherapy and Photo-Immunometabolic Therapy. | Wiley Interdiscip Rev Nanomed Nanobiotechnol | 2025 | https://conductscience.org/library/papers/41363830 | PubMed |
| 41357129 | Scavenging of reactive oxygen and nitrogen species using nanoparticles and their applications in disease management. | RSC Adv | 2025 | https://conductscience.org/library/papers/41357129 | PubMed |
| 41246345 | Mitochondria-targeted strategies in tumor immunity. | Front Immunol | 2025 | https://conductscience.org/library/papers/41246345 | PubMed |
| 40696413 | Decoding the metabolic dialogue in the tumor microenvironment: from immune suppression to precision cancer therapies. | Exp Hematol Oncol | 2025 | https://conductscience.org/library/papers/40696413 | PubMed |
| 40694096 | Dual-targeted protein-coated PLGA nanoparticles for pancreatic cancer therapy: a novel approach using esculetin and curcumin. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/40694096 | PubMed |
| 40630838 | Nanotherapeutic System with Effective Microwave Sensitization and Pyroptosis Programming Enable Synergistic Microwave-Immunotherapy in Bladder Cancer. | Biomater Res | 2024 | https://conductscience.org/library/papers/40630838 | PubMed |
| 40585764 | Harnessing Biomarker Activatable Probes for Early Stratification and Timely Assessment of Therapeutic Efficacy in Cancer. | Exploration (Beijing) | 2025 | https://conductscience.org/library/papers/40585764 | PubMed |
| 40542357 | An oxygen-generating nanoplatform remodels the immunosuppressive tumor microenvironment via synergistic lactate depletion and sonodynamic therapy. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/40542357 | PubMed |
| 40500674 | Optogenetic engineering for precision cancer immunotherapy. | Trends Pharmacol Sci | 2025 | https://conductscience.org/library/papers/40500674 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33009382
GET https://conductscience.org/api/papers/v1/33009382/cited_by?page=2